Skip to content

BProSOFT CASP PC Software

by Healthstats International Pte Ltd

510(k) K131916

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK131916 Date11 Mar 2014ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DXN
FDA applicant
Healthstats International Pte. , Ltd.
Device Class
Class II
Regulation
21 CFR Part 870.1130
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The BProSOFT CASP PC Software is a Computer Software Product for Medical Purposes designed to analyze arterial pulse waveforms from ambulatory blood pressure monitoring systems. It calculates central aortic systolic pressure (CASP) in addition to standard blood pressure parameters, supporting cardiovascular assessment and hypertension management.

This software is intended for use with compatible ambulatory blood pressure monitoring devices, functioning as a standalone analytical tool for healthcare professionals. Supplied as a digital product, it requires no sterility or single-use considerations and is not subject to MRI safety constraints. Authorized under FDA 510(k) clearance (K131916) as substantially equivalent, it operates within the regulatory framework for cardiovascular software submissions.

Other devices from Healthstats International Pte Ltd

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What specific type of blood pressure data does the BProSOFT CASP software analyze, and how does it differ from standard blood pressure monitoring tools?

    The BProSOFT CASP software analyzes arterial pulse waveforms from ambulatory blood pressure monitoring systems, going beyond standard tools by calculating central aortic systolic pressure (CASP). While traditional monitors measure brachial blood pressure, this software provides additional cardiovascular insights—like aortic pressure—which can help assess hypertension and cardiovascular risk more comprehensively.

  • Is this software compatible with any specific ambulatory blood pressure devices, or does it require particular hardware to function?

    The BProSOFT CASP software is designed to work only with compatible ambulatory blood pressure monitoring devices, though the exact models aren’t listed in the data. It functions as a standalone analytical tool, meaning it relies on data exported from those devices rather than operating as a standalone monitor itself. Always verify compatibility with your existing equipment before use.

  • Since this is a digital product, how is it supplied, and do I need to worry about sterility or single-use considerations?

    The software is supplied digitally—no physical hardware or consumables are involved. Because it’s a computer program, there are no sterility or single-use requirements like with medical devices that contact patients. It’s intended for use on a PC, so no additional handling precautions apply beyond standard IT security and software installation guidelines.

  • What regulatory pathway was followed for this software, and which advisory committee was involved in its review?

    The BProSOFT CASP software underwent a traditional FDA 510(k) review under the Cardiovascular (CV) advisory committee, with a decision code of SESE (Substantially Equivalent). This means it was deemed comparable to a legally marketed device in terms of technology and performance, ensuring its safety and effectiveness for calculating central aortic systolic pressure in clinical settings.